Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

STRATA Skin Sciences (SSKN) Net Cash Flow (2016 - 2025)

Historic Net Cash Flow for STRATA Skin Sciences (SSKN) over the last 14 years, with Q3 2025 value amounting to $1.1 million.

  • STRATA Skin Sciences' Net Cash Flow fell 2970.23% to $1.1 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$1.3 million, marking a year-over-year decrease of 181304.35%. This contributed to the annual value of $477000.0 for FY2024, which is 6394.56% down from last year.
  • According to the latest figures from Q3 2025, STRATA Skin Sciences' Net Cash Flow is $1.1 million, which was down 2970.23% from -$1.9 million recorded in Q2 2025.
  • STRATA Skin Sciences' 5-year Net Cash Flow high stood at $6.2 million for Q2 2023, and its period low was -$4.0 million during Q3 2021.
  • Its 5-year average for Net Cash Flow is -$580842.1, with a median of -$749000.0 in 2025.
  • In the last 5 years, STRATA Skin Sciences' Net Cash Flow crashed by 2945000.0% in 2021 and then skyrocketed by 80000.0% in 2023.
  • STRATA Skin Sciences' Net Cash Flow (Quarter) stood at -$461000.0 in 2021, then tumbled by 338.18% to -$2.0 million in 2022, then soared by 82.82% to -$347000.0 in 2023, then soared by 157.35% to $199000.0 in 2024, then surged by 457.79% to $1.1 million in 2025.
  • Its last three reported values are $1.1 million in Q3 2025, -$1.9 million for Q2 2025, and -$749000.0 during Q1 2025.